You are here

XPhyto Therapeutics Corp.

Listing Exchange: 
CSE
Status: 
Active
Industry: 
Life Sciences
Symbol: 
XPHY
CSE Index: 
Currency: 

XPhyto Therapeutics Corp. (“XPhyto”) is a bioscience accelerator focused on next-generation drug delivery, diagnostic, and new active pharmaceutical ingredient investment opportunities, including: precision transdermal and oral dissolvable drug formulations; rapid, low-cost infectious disease and oral health screening tests; and standardization of emerging active pharmaceutical ingredients for neurological applications, including psychedelic compounds and cannabinoids. The Company has research and development operations in North America and Europe, with an operational focus in Germany, and is currently focused on regulatory approval and commercialization of medical products for European markets.

You are here

XPhyto Therapeutics Corp. (XPHY)

SEDAR Information

Company Info

Address
Suite 270 - 1820 Fir Street
Vancouver, BC V7Y 1G5
Canada
Phone
780-818-6422
Email
info@xphyto.com
Listing date
Wednesday, July 31, 2019
Transfer Agent
Computershare Investor Services Inc.

Advertisement

Publicité

Capitalization

Issued & Outstanding: 
64,240,224
Reserved for Issuance: 
23,983,765

Bulletins

30/07/2019

2019-0724 – New Listing - XPhyto Therapeutics Corp. (XPHY)

le 30 juillet/July 2019

The common shares of XPhyto Therapeutics Corp. have been approved for listing on the CSE.

Listing and disclosure documents will be available at www.thecse.com on the trading date.

Advertisement

Publicité

Latest CSE News

Upcoming Events

PDAC_website.png

Virtual PDAC 2021

Monday, March 8, 2021 to Thursday, March 11, 2021
PDAC_Invite_2021_CSE_Website_740x374_1.jpg

Ridi, Bevi, e Divertiti

Tuesday, March 9, 2021 -
3:00pm to 5:00pm